Assessing the burden of adverse events in a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia (CLL) Meeting Abstract
| Authors: | Seymour, J. F.; Byrd, J. C.; Munir, T.; Ghia, P.; Kater, A. P.; Chanan-Khan, A.; Furman, R. R.; O'Brien, S.; Brown, J. R.; Mato, A. R.; Stilgenbauer, S.; Fehn, T.; de Miranda, P. A. P.; Higgins, K.; John, E.; de Borja, M.; Jurczak, W.; Woyach, J. A. |
| Abstract Title: | Assessing the burden of adverse events in a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia (CLL) |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 7050 |
| End Page: | 7052 |
| Language: | English |
| ACCESSION: | WOS:000893230300023 |
| DOI: | 10.1182/blood-2022-157060 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
